(
(
Healthcare
Healthcare
)
)
Novel transcatheter mitral valve replacement
Novel transcatheter mitral valve replacement
Novel transcatheter mitral valve replacement
STATUS:
Current
HighLife is a trans-catheter mitral valve replacement company committed to bringing the best minimally invasive technology to the patients.
HighLife is a trans-catheter mitral valve replacement company committed to bringing the best minimally invasive technology to the patients.
(Entrepreneurs)
(Entrepreneurs)
Stefan Pilz, CEO
Steve Backer, COO
Prof. Stephen Brecker, CMO
(VI Partners)
(VI Partners)
(Fund)
(Fund)
Vi-21
Vi-21
Portfolio News
SEP 22, 2026
HighLife Raises $90+Million to start its US Pivotal Study and accelerate Commercial Expansion in Europe
Read More
Read more
SEP 22, 2026
HighLife Raises $90+Million to start its US Pivotal Study and accelerate Commercial Expansion in Europe
Read More
Read more
AUG 27, 2026
HighLife Receives CE Mark Approval for Clarity Valve, the Next-Generation Valve for the HighLife TMVR System
Read More
Read more
AUG 27, 2026
HighLife Receives CE Mark Approval for Clarity Valve, the Next-Generation Valve for the HighLife TMVR System
Read More
Read more
APR 07, 2025
HighLife granted US FDA Breakthrough Device Designation for its TMVR solution
Read More
Read more
APR 07, 2025
HighLife granted US FDA Breakthrough Device Designation for its TMVR solution
Read More
Read more